{"id":1015050,"date":"2026-10-29T09:59:23","date_gmt":"2026-10-29T13:59:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/"},"modified":"2026-10-29T09:59:23","modified_gmt":"2026-10-29T13:59:23","slug":"minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/","title":{"rendered":"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BURLINGTON, Mass., Oct.  29, 2026  (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in the 2026 Jefferies Global Healthcare Conference in London.<\/p>\n<p>\n        <strong>2026 Jefferies Global Healthcare Conference<\/strong><br \/>\n        <br \/>Dates: Monday, November 16 &amp; Tuesday, November 17, 2026 <br \/>Format: Fireside chat and 1&#215;1 meetings<br \/>Fireside Chat: Monday, November 16, 2026 from 4:00 \u2013 4:25 p.m. GMT <br \/>Location: London, UK<\/p>\n<p>If you are interested in meeting with the Minerva team during the conference, please reach out to your respective Jefferies representative.<\/p>\n<p>The live webcast can be accessed in the events section of the Minerva Neurosciences website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SYg0qpxfmydyjk2oGjwu-0oLUZm4lKYEb6fbjdiV5d2yTF8sYYlMLhrsIu-_bKsfQF-46Yu7xkpJjsJEUWR3NSn0RpzaRk0C2mQ9ufWgq-AG2c4B4SHTtwh7tUsCYHLG\" rel=\"nofollow\" target=\"_blank\">HERE<\/a>. Access to the webcast replay will be available approximately two hours after the completion of the event and will be archived on the Company\u2019s website.<\/p>\n<p>\n        <strong>About Minerva Neurosciences<\/strong>\n      <\/p>\n<p>Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is conducting a confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia. For more information, please visit the Company\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gIQ35jb6fKU9d38kH5gamxMhDq1Nwb9pFSq1WqSjkTbmFvZBtxtBSvvzi5WDlEc6c0WFuzJvtaMu3yEeQKN-86ZOxZF3jw3RKzmFKWaYJRk=\" rel=\"nofollow\" target=\"_blank\">website<\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong><br \/>\n        <br \/>\n        <strong>Frederick Ahlholm<\/strong><br \/>\n        <br \/>Chief Financial Officer<br \/>Minerva Neurosciences, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ufoZmvfubSmrrRuzxqX7Rwfo9PwPygdBwNq6rsUuRdea7OvvcfIxaSja2WMdKakQsqKpqywGZjxZ2ZmFP4RleCOx3Y4QVDPSVGj6-gYs_OK28XyHf8Wse5MLmeQZvMca4X_bpxCAacvLU12CDu50TA==\" rel=\"nofollow\" target=\"_blank\">FAhlholm@minervaneurosciences.com<\/a><\/p>\n<p>\n        <strong>Corey Davis, Ph.D.<\/strong><br \/>\n        <br \/>LifeSci Advisors, LLC<br \/>212-915-2577<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=t4VadTy-SvQc6q2iRDJ1wVJERRn7jrWPCqPynrXcJYe9jitQJb9dPKij7qS2rXS8ZcuE148y9F1F4LaqkQUBLhoPUmyzIKqwY3PMA4WTSDy-Hb2yecWRBcnNkh-HtlDe\" rel=\"nofollow\" target=\"_blank\">cdavis@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzU4MDJhMmEtNDg3OC00Y2FiLWIzNGEtNjVhNzZlMTBjMjI3LTEwMTg4MTgtMjAyNi0xMC0yOS1lbg==\/tiny\/Minerva-Neurosciences-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BURLINGTON, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in the 2026 Jefferies Global Healthcare Conference in London. 2026 Jefferies Global Healthcare Conference Dates: Monday, November 16 &amp; Tuesday, November 17, 2026 Format: Fireside chat and 1&#215;1 meetingsFireside Chat: Monday, November 16, 2026 from 4:00 \u2013 4:25 p.m. GMT Location: London, UK If you are interested in meeting with the Minerva team during the conference, please reach out to your respective Jefferies representative. The live webcast can be accessed in the events section of the Minerva Neurosciences website HERE. Access to the webcast replay &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1015050","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BURLINGTON, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in the 2026 Jefferies Global Healthcare Conference in London. 2026 Jefferies Global Healthcare Conference Dates: Monday, November 16 &amp; Tuesday, November 17, 2026 Format: Fireside chat and 1&#215;1 meetingsFireside Chat: Monday, November 16, 2026 from 4:00 \u2013 4:25 p.m. GMT Location: London, UK If you are interested in meeting with the Minerva team during the conference, please reach out to your respective Jefferies representative. The live webcast can be accessed in the events section of the Minerva Neurosciences website HERE. Access to the webcast replay &hellip; Continue reading &quot;Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-29T13:59:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London\",\"datePublished\":\"2026-10-29T13:59:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/\"},\"wordCount\":207,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/\",\"name\":\"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=\",\"datePublished\":\"2026-10-29T13:59:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/","og_locale":"en_US","og_type":"article","og_title":"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London - Market Newsdesk","og_description":"BURLINGTON, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) &#8212; Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in the 2026 Jefferies Global Healthcare Conference in London. 2026 Jefferies Global Healthcare Conference Dates: Monday, November 16 &amp; Tuesday, November 17, 2026 Format: Fireside chat and 1&#215;1 meetingsFireside Chat: Monday, November 16, 2026 from 4:00 \u2013 4:25 p.m. GMT Location: London, UK If you are interested in meeting with the Minerva team during the conference, please reach out to your respective Jefferies representative. The live webcast can be accessed in the events section of the Minerva Neurosciences website HERE. Access to the webcast replay &hellip; Continue reading \"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-29T13:59:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London","datePublished":"2026-10-29T13:59:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/"},"wordCount":207,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/","name":"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=","datePublished":"2026-10-29T13:59:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTgxNyM3OTIyOTUzIzIwMDcyNDU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/minerva-neurosciences-to-participate-in-2026-jefferies-global-healthcare-conference-in-london\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1015050"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015050\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1015050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1015050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1015050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}